Spring Pharmaceutical Group, Inc. (CYIG) financial statements (2022 and earlier)

Company profile

Business Address 11 QUANXING ROAD
SICHUI, 273200
State of Incorp. FL
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25,35310,3097,63913,08418,62529,924
Cash and cash equivalents25,35310,3097,63913,08418,62529,924
Receivables1751,1355339642135
Inventory, net of allowances, customer advances and progress billings2,3835,4832,2878971,5931,297
Inventory2,3835,4832,2878971,5931,297
Prepaid expense and other current assets21
Other undisclosed current assets2,1541,551962686360 
Total current assets:30,06618,47811,42114,76220,61931,377
Noncurrent Assets
Property, plant and equipment16,79314,48712,87312,86413,3859,410
Intangible assets, net (including goodwill)11,86212,04312,29515,39316,68417,657
Intangible assets, net (excluding goodwill)11,86212,04312,29515,39316,68417,657
Other undisclosed noncurrent assets51,41745,27944,72634,13916,532221
Total noncurrent assets:80,07271,80969,89462,39646,60127,287
TOTAL ASSETS:110,13890,28781,31677,15867,22058,664
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:373251190145817887
Taxes payable1,1642,0287391,603817887
Other undisclosed accounts payable and accrued liabilities(791)(1,777)(549)(1,458)  
Due to related parties 706    
Other liabilities    30367
Other undisclosed current liabilities1,6102,0287761,603  
Total current liabilities:1,9832,9869661,7488461,254
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 2,423    
Total noncurrent liabilities: 2,423    
Total liabilities:1,9835,4099661,7488461,254
Stockholders' equity
Stockholders' equity attributable to parent, including:105,10787,30180,35075,40966,37457,411
Preferred stock232323232323
Common stock303030303030
Additional paid in capital4,3234,3234,6484,2104,1804,180
Accumulated other comprehensive income (loss)4,455(4,387)8374,7524,6373,795
Retained earnings94,44884,89074,81266,39557,50549,384
Other undisclosed stockholders' equity attributable to parent1,8292,423    
Stockholders' equity attributable to noncontrolling interest3,049     
Other undisclosed stockholders' equity (2,423)   (0)
Total stockholders' equity:108,15584,87880,35075,40966,37457,411
TOTAL LIABILITIES AND EQUITY:110,13890,28781,31677,15867,22058,664

Income statement (P&L) ($ in thousands)

3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
Revenues64,94356,46347,82737,94334,06333,103
Revenue, net 13447,827 34,06333,103
Cost of revenue
(Cost of Goods and Services Sold)
(39,604)(33,284)(26,554)(20,023)(17,407)(17,303)
Other undisclosed gross profit   1,4491,2731,126
Gross profit:25,33923,17921,27319,37017,92816,925
Operating expenses(10,528)(9,978)(10,046)(7,571)(7,210)(7,742)
Operating income:14,81013,20111,22711,79910,7189,183
Nonoperating income (expense)
(Investment Income, Nonoperating)
 5531(86)  
Other undisclosed income from continuing operations before equity method investments, income taxes767  172798,404
Income from continuing operations before income taxes:15,57713,25511,25811,88510,79817,587
Income tax expense (benefit)(3,839)(3,201)2,8412,995(2,677)(2,326)
Net income:11,73810,05514,09914,8808,12115,261
Net income attributable to noncontrolling interest 24    
Other undisclosed net loss attributable to parent  (5,682)(5,989)  
Net income attributable to parent:11,73810,0788,4178,8908,12115,261
Other undisclosed net loss available to common stockholders, basic(352)     
Net income available to common stockholders, diluted:11,38610,0788,4178,8908,12115,261

Comprehensive Income ($ in thousands)

3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
Net income:11,73810,05514,09914,8808,12115,261
Other undisclosed comprehensive income (loss)8,490(5,200)    
Comprehensive income:20,2284,85414,09914,8808,12115,261
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(626)28    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,251(56)(9,597)(5,874)842454
Comprehensive income, net of tax, attributable to parent:20,8544,8264,5029,0058,96315,715

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: